Slowing down your stomach: GLP-1 puts the brakes on how fast food moves out of your stomach, so you feel full longer
High-yield reporting fields for suspected semaglutide-related vaginal symptoms include: dose and escalation dates, concomitant SGLT2 inhibitor use, antibiotic/antifungal use, menopausal status/HRT, diabetes control markers, symptom description with onset/offset, objective test results (pH, microscopy/NAAT), and dechallenge/rechallenge outcomes if they occur
The estimated effects on blood glucose and body weight were largest in 2021, immediately after GLP-1s were included in the VHA formulary
"S100A6 preferentially labels type C nevus cells and nevic corpuscles: additional support for Schwannian differentiation of intradermal nevi."
Patients with personal/family history of medullary thyroid carcinoma or MEN2 syndrome are not candidates
Blood sugar regulation: Retatrutide can maintain consistent blood sugar levels throughout the day by activation of GLP-1 and GIP receptors
